Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Armata Pharmaceuticals, Inc. | v461502_ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc. | v461502_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc. | v461502_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc. | v461502_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Armata Pharmaceuticals, Inc. | v461502_ex21-1.htm |
| 10-K - FORM 10-K - Armata Pharmaceuticals, Inc. | v461502_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-1 Nos. 333-213421 and 333-203454) of AmpliPhi Biosciences Corporation, |
| (2) | Registration Statement (Form S-3 No. 333-210974) of AmpliPhi Biosciences Corporation, |
| (3) | Registration Statement (Form S-8 No. 333-203455) pertaining to the 2012 Stock Incentive Plan and 2013 Stock Incentive Plan, and |
| (4) | Registration Statement (Form S-8 No. 333-212183) pertaining to the AmpliPhi Biosciences Corporation 2016 Employee Stock Purchase Plan and AmpliPhi Biosciences Corporation 2016 Equity Incentive Plan; |
of our report dated March 27, 2017, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation included in this Annual Report (Form 10-K) of AmpliPhi Biosciences Corporation for the year ended December 31, 2016.
/s/ Ernst & Young LLP
San Diego, California
March 27, 2017